Professional Documents
Culture Documents
AQUATIC CHICKEN
SOURCE: FAO
Successful and sustainable in fish farming come from
successful in fish health managements
Health Booster
(Probiotics,
immunostimutants,
vaccines)
Farm, water
quality and
Nutritions environmental
management
Successful
in fish
farming
Breed
farming skills
and Basic
(diseases
Knowledges resistance
Fish)
Biosecurity
5
Fish health management
6
Failure of fish health management
Diseases
7
Important infectious diseases
of Tilapia
• Streptococcosis
• Columnaris
• Franciscellosis
8
Tilapia major diseases
10
Columnaris disease
11
Bacterial hemorrhagic septicemia
12
Franciscellosis
Tilapia Tilapinevirus infection
14
Important diseases of Sea Bass
Marine culture
• Streptococcosis
• Taenecibaculosis
• Scale drop and muscle necrosis from Vibrio spp. (Vibriosis)
• Scale drop disease virus infection
• Infectious spleen and kidney necrosis virus (ISKNDV) infecttion
• Viral Nervous Necrosis (VNN) virus infection
• Iridovirus infection
• Parasite
Freshwater culture
• Streptococcosis
• Columnaris
• Aeromonas septicemia
15
Diseases of Sea Bass
Emerging diseases
17
Taenecibaculosis in marine culture Sea Bass
18
Scale Drop Disease virus (SDDV) infection
19 https://doi.org/10.1111/jfd.12915
Bacterial Scale Drop and Muscle Necrosis disease
(SDMND)
20 https://aquahealth.wordpress.com
Infectious Spleen and Kidney Necrosis virus (ISKNDV) infection
21 https://aquahealth.wordpress.com
Viral Nervous Necrosis (VNN)
22
https://thefishsite.com/articles/diseases-of-farmed-barramundi-in-asia
Iridovirus infection
23
https://thefishsite.com/articles/diseases-of-farmed-barramundi-in-asia
Streptococcosis
https://thefishsite.com/articles/diseases-of-farmed-barramundi-in-asia
24
Molecular research workflow for aquatic animal
pathogens and their antimicrobial resistance
25
CASE STUDY ON FLAVOBACTERIUM INFECTION
P. shigelloides
V. cholerae
S. agalactiae
F. columnare
Result of specific PCR diagnosis
Concurrent infection of bacteria and virus
found in two affected tilapia farms.
F. A. S. Francisella P. V. Iridovirus Number of
columnar veronii agalactia spp. shigeloides cholerae pathogens
per fish
e e
CFUs, colony forming units; I.P., intraperitoneal; I.M., intramuscular; TSB, tryptic soy broth
F. columnare
A. veronii
Other evidence of concurrent infection
during disease outbreaks (1)
Naturally Experimentally
diseased fish diseased fish
Virulence and Characterization of
Flavobacterium columnare from Diseased Tilapia
Conceptual Framework
F. columnare isolates
41
BACTERIAL ISOLATION & IDENTIFICATION (1)
49 isolates
Red tilapia: n=44
Nile tilapia: n=1
Striped catfish: n=3
42 Koi carp: n=1 Phenotypic tests (Bernadet, 1989) Specific PCR (Welker et al., 2005)
GENETIC CHARACTERIZATION OF F. COLUMNARE (1)
➢ 16S RNA sequencing & Phylogenetic analysis (n=19) (Darwish et al., 2005)
43
GENETIC CHARACTERIZATION OF F. COLUMNARE (2)
II I
M
~ 600 bp
500 bp ~ 430 bp
300 bp ~ 290 bp
~ 276 bp
200 bp ~ 180 bp
100 bp
Unique cluster
F. columnare CUVET1213
F. columnare CUVET1367
F. columnare CUVET1355
F. columnare CUVET1351
F. columnare CUVET1350
85 F. columnare CUVET1349
F. columnare CUVET1348 18 isolates
F. columnare CUVET1347
F. columnare CUVET1345
56 F. columnare CUVET1221
F. columnare CUVET1204
F. columnare CUVET1346
85 F. columnare CUVET1338
F. columnare CUVET-BU
98 F. columnare CUVET1336
50 F. columnare CUVET1212
64
F. columnare CUVET1343
F. columnare CUVET1214
F. columnare CUVET1201
F. columnare CUVET1202
F. columnare CUVET1203
7 isolates 100
F. columnare CUVET1340
F. columnare CUVET1341
F. columnare CUVET1344
F. columnare CUVET1362
47
0.005
GENETIC CHARACTERIZATION (5)
50
G
83
F. columnare BZ-04 Branch II
99 F. columnare BZ-01 F
97
99 F. columnare BZ-02
F. columnare BZ-05 E
99 F. columnare CUVET1231
100 F. columnare CUVET1232 D
96 F. columnare ALG-00-530
81 F. columnare EK 28
64 F. columnare LP 8
•
F. columnare CUVET1344
GenBank seq (n=17) 99 F. columnare CUVET1338 Sub-cluster
Sub-cluster IIB
• 1180 bp (position 90-1278 E. coli
F. columnare CUVET1214 IIB
F. columnare CUVET1213
numbering) F. columnare CUVET1212
Cluster
F. columnare CUVET1204
Cluster II
• Unique cluster ISR-G (n=16) 54
F. columnare CUVET1203
F. columnare CUVET1202 II
formed a sub-cluster IIB F. columnare CUVET1201
F. columnare CUVET1350
F. columnare LP8
72
F. columnare EK28 Sub-cluster
F. columnare LV339-01
90 F. columnare Ga-6-93 IIA
98 Sub-cluster IIA
F. columnare ALG-00-530 clone GII-18
F. columnare PT-14-00-151 clone GIIB-1
Genomovar II-B → 61
F. columnare CUVET1231
69 F. columnare CUVET1232
F. columnare ATCC 49512
99 57 F. columnare ATCC 23463 clone GI-1
Genomovar I/II →
99
F. columnare F10-HK-A clone GI/II-1
F. columnare IAM 14301 Cluster I
Cluster I
98
F. columnare FK 401
76 F. columnare ATCC 49513
F. columnare CUVET1215
99
F. columnare AU-98-24 Cluster
Genomovar I (CUVET1215) →
F. columnare PH-97028 Cluster III
86
97 F. columnare GA-02-14 clone GIII-1 III
52 F. columnare ARS-1 clone GIA-1
Flavobacterium johnsoniae ATCC 23107
Flavobacterium psychrophilum strain ATCC 49418
75 Flavobacterium branchiophilum NBRC 15030.
CUVET1214 CUVET1201
Upon primary isolation, both isolates formed yellow-
pigmented rhizoid colonies on AO agar
CUVET1201 transformed to non-rhizoid under the
preservation condition in the laboratory
51
VIRULENCE OF RHIZOID AND NON-RHIZOID
MORPHOTYPES (2)
Virulence assay
Naturally Experimentally
diseased fish diseased fish
53
VIRULENCE OF RHIZOID AND NON-RHIZOID
MORPHOTYPES (4)
Adhesion & Persistence
56
STREPTOCOCCOSIS IN FISH
CAUSATIVE AGENTS
• Non-motile, non spore-forming and Gram-
positivestreptococcus related species
– Streptococcus agalactiae (Group B
streptococci)
– S. iniae
– Lactococcus garvieae
– S. dysgalactiae, S. parauberis, etc.
• Produce either complete- (β), incomplete-
(α) haemolysis
57
•GRAM POSITIVE,
ENCAPSULATED,
COCCI, NON-SPORE
FORMING AND MOSTLY
ß-HEMOLYSIS
• WIDE HOST-RANGE
PATHOGEN
58
STREPTOCOCCOSIS IN FISH
59
60
• Increasing of water temperature can significantly exacerbate
disease virulence
8 80
6 60
4 40
2 20
0 0
0 6 12 24 48 72 96 1 2 3 4 5 6 7 8 9 10 11 12 13 14
time (hpi) day post infection (dpi)
S. agalactiae
(Group B Streptococci)
S. iniae
L. garvieae (FROM
PRAWN)
62
VARIABILITY OF S. agalactiae IN
THAILAND
SUB-SPECIES
CATEGORIZATION
• Serotyping (Ia, Ib, II-IX)
– Human: Ia, III, V
– Bovine: non-specific
serotype
– Fish: Ia, Ib, III
• Cross-protection of
heterologous serotype is
very limited (Cieslewicz et al., 2005)
DISTRIBUTION OF S. agalactiae SEROTYPE
CHINA &
NORTH
CENTRAL ASIA
AMERICA
Ia Ia, Ib
EUROPE
Ia SEA
Ia, Ib, III
SOUTH
AMERICA
Ib AUSTRALIA
Ia
64
Most were identified as molecular
serotype Ia (only 2 isolates were type III)
• Serotype Ia was the majority of the
fish originated S. agalactiae in
Thailand (Suanyuk et al., 2008)
(Lukkana, 2015)
66
CONCLUSION
67
DISTRIBUTION OF S. agalactiae SEROTYPE
(Personal communication)
SEROTYPE Ia,
III (highly pathogenic)
(Kayansamruaj, 2014)
SEROTYPE Ia
(Suanyuk, 2008)
SEROTYPE Ia,
III (human originated
strain)
68
Research Outcome
69
Research outcome
70
Research Outcome
71
Case study of Franciscellosis in
Tilapia
Distribution of Franciscellosis in fish
76
Manuel, 2010
Fno -> francisellosis
Media Optimum
Cystine heart agar + 5 % sheep blood Growth condition
temperature:
aerobic
(Soto et al., 2009) 25-28 °c
- PCR
- Histology (H&E,
Giemsa, Gram stain)
- Bacterial isolation
(CHA, TSA)
DNA
Primers extraction
Sequence (5’-3’) Target gens References
F11 TACCAGTTGGAAACGACTGT 16S rRNA of Forsman et al.,
• Bacterial
F5
colony sample: boilingFrancisella.
CCTTTTTGAGTTTCGCTCC
methodsp (Shah et al.,
19942012)
F1 GAGTTTGATCCTGGCTCAG 16S rRNA
• Fish tissue sample (spleen, kidney):(Universal
DNeasy bloodDorsch
& tissue
&
R13 AGAAAGGAGGTGATCCAGCC Stackebrandt 1992
kit (Qiagen) primer)
10
Data analysis
• Sequencing analysis
• CLUSTALX 2.0
• BLASTN program.
• MEGA10
• One-way ANOVA to test difference between each experimental
groups
79
RESULTS
Bacterial identification
M: 1 kb ladder
1 kb
1-2: Healthy fish
3-12: Affected fish
Figure 1: PCR diagnosis of Francisella sp. from
affected red tilapia using genus-specific primers.
A B
Figure : Fno VMCU-FNO 131 on CHA (A) and Gram staining (B)
Control fish
21
RESULTS
A B
Figure : . A) Granulomas formation (G) in infected red tilapia
and granuloma in high magnificent. B) Normal tissue from
control fish.
84
Histological lesions of red tilapia affected by Fno
K
S
A B
L I
D C
85
Typical granuloma caused by Fno infected in red tilapia
Early
stage
20 µm A B 20 µm
Last Mature
stage stage
20 µm
D C 20 µm
24
Histological lesions of control red tilapia
K
S
A B
L I
D C 25
RESULTS
A B
Figure 9: A) Primary and secondary gill lamella of infected red tilapia
presented hyperplasia and fusion, and granulomas inflammation at basal of
gill arch. B) Normal gill of control fish. H&E stain.
26
RESULTS
Recovered
isolates
(B)
Challenge
red tilapia
(A)
27
RESULTS
100
90
Cumulative mortality %
80
70
60
2.88
Dose 1x 105 CFU per fish
50
2.88
Dose 2x 103 CFU per fish
40 Control
Control
30
20
10
0
1 3 5 7 9 11 13 15 17 19
28
RESULTS
• Clinical signs
• White nodules were only observed in dose 105,
104, 103 CFU fish-1 via i.p
• Other doses: enlarged internal organs
• West mount and histological finding in both i.p
and immersion route were common with previous
experimental challenge
29
RESULTS
100
90
Cumulative mortality %
7Dose
x 10
1 6 CFU mL-1
80
70 2.88
Dose 2 x 105 CFU mL-1
60
2.88
Dose 3 x 104 CFU mL-1
50
40
2.88
Dose 4 x 103 CFU mL-1
30 Control
Control
20
10
0
Day
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
30
RESULTS
90
Cumulative mortality %
80
70 2.881x
Dose 105 CFU per fish
60 2.882x
Dose 104 CFU per fish
Dose 3
50 2.88 x 103 CFU per fish
Dose 4
40 2.88 x 102 CFU per fish
COntrol
30 Control
20
10
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Day
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
2 kb
Challenged
1 kb
red tilapia
(A)
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 P N
1 kb Recovered
(B) isolates
Figure 15: A) 1-10: infected fish in injection group; 11-21: infected fish in
immersion group; P: positive control; N: DNA extracted from control fish.
B) M: DNA marker; 1-14: isolates recovered from injection groups; 15-17:
isolates recovered from dose 105 & 106 CFU mL-1 of immersion groups.
33
Table : Summary of Francisella noatunensis subsp. orientalis
VMCU-FNO131 virulence assay in red tilapia
94
95
CASE STUDY :
Genome Characterization of Quinolone Resistance
Associated Genes of Flavobacterium columnare
Isolated from Columnaris Diseased Asian Sea Bass
(Lates calcarifer)
Putita Chokmangmeepisarn
Advisor : Asst. Prof. Dr. Channarong Rodkhum
Co-advisor : Dr. Pattanapon Kayansamruaj
Flavobacterium columnare
96 Vibrio sp.
IMPORTANCE & RATIONAL
Flavobacterium columnare
97
(Bernardet and Bowman, 2006)
IMPORTANCE & RATIONAL
Columnaris disease
▪ A highly contagious disease
causing by bacteria
“Flavobacterium columnare“
▪ The pathogen commonly affect to
gills, skin, and fins
▪ yellow-grey opalescent necrotic
patches or erosions are visible on
the skin
▪ Severe tissue necrosis develops
into “saddleback” lesions on the
dorsum
▪ The lack of commercial vaccine
promote the use of antibiotics to
prevent and control the disease
(Dong, 2014)
IMPORTANCE & RATIONAL
Antibiotic use
(DOF, 2012)
100
IMPORTANCE & RATIONAL
Antimicrobial
susceptibility tests
▪ High-throughput sequencing
▪ Rapid
▪ Become more feasible
▪ Bioinformatics tools and free-access
databases are available
Advantages
▪ Predicted the antimicrobial
resistance and associated
genes
▪ Tracking a multi-drug
resistance mechanism
▪ Investigated horizontal gene
transfer
▪ Identify novel resistance gene
(Zankari et al., 2012)
103
Detection of AMR genes
Resistome analysis
105
MATERIALS & METHODS
Sample collection &
Bacterial isolation
Sample colllection
106
106
MATERIALS & METHODS
Sample collection &
Bacterial isolation
Bacterial identification
107
MATERIALS & METHODS
Antimicrobial
susceptibility tests Disk diffusion method
110
MATERIALS & METHODS
Genome analysis
workflow
de novo assembly
Annotation
Rapid Annotation using
The Comprehensive Antibiotic Resistance Database Subsystem Technology (RAST)
111
Resfinder
RESULTS & DISCUSSION
Sample collection
& bacterial isolation
FID RU
Gram Negative
Morphology Slender long rod
Growth on TSA -
Growth on MAC -
Flexirubin pigment +
Catalase +
Cytochrome oxidase +
FID RU Gliding motility +
Decarboxylase test
Gram staining Arginine -
Lysine -
Ornithine -
114
RESULTS & DISCUSSION
Bacterial identification
Molecular identification
M N 1 2 3 4 5 6 7 8 9 101112131415
20
15
10
0
Antibiotics
OA NA CIP ENR OT AML FFC
Resistant
Antibiotics
Isolates
OA NA ENR CIP OT AML FFC
CC1801 S S S S S S S
CC1802 S S S S S S S
CC1803 S S S S S S S
CC1805 S S S S S S S Quinolone
CC1806 S S S S S S S Sensitive
CC1807 S S S S S S S (QS)
CC1808 S S S S S S S group
CC1809 S S S S S S S
SP1801 R R S S S S S
SP1802 R R S S S S S
SP1803 R R S S S S S
Quinolone
SP1805 S R S S S S S
Resistance (QR)
SP1806 R R S S S S S
group
SP1808 S S S S S S S
117
SP1809 R R S S S S S
RESULTS & DISCUSSION
Antimicrobial susceptibility
Broth microdilution
MIC (μg/mL)
Isolates
OA NA ENR
CC1801 0.25 2 <0.125
CC1802 0.125 2 <0.125
CC1803 0.25 0.25 <0.125
CC1804 0.25 0.25 <0.125
CC1805 0.25 4 <0.125
CC1806 0.25 4 <0.125
CC1807 0.25 4 <0.125
CC1808 8 <0.125 0.25
SP1801 32 >64 1
SP1802 32 >64 1
SP1803 8 >64 1
SP1805
SP1806
0.5
8
>64
>64
0.25
1
▪ 7 isolates were
118
SP1808 0.5 >64 0.5 selected for NGS
SP1809 16 >64 1
RESULTS & DISCUSSION
Genome features
119
RESULTS & DISCUSSION
Antimicrobial resistance genes
prediction
Overview of AMR genes by
1 1
2
QS group 2 QR group
Total 165 genes Total 173 genes
were predicted were predicted
3 3
4
5 4 5
1. Tetracycline 1. Macrolide
2. Macrolide 2. Tetracycline
3. Fluoroquinolne 3. Fluoroquinolne
4. Peptide antibiotic 4. Glycopeptide antibiotic
120
5. Glycopeptide antibiotic 5. Peptide antibiotic
RESULTS & DISCUSSION
Antimicrobial resistance genes
prediction Quinolone resistance (QR)
associated gens
QS group QR group
121
RESULTS & DISCUSSION
Antimicrobial resistance genes
prediction Quinolone resistance (QR)
associated gens
Resistance
Gene family Genes No.
Mechanisms
acrS, adeL, adeN, cmeA, cmeB, cmeC, acrA,
RND antibiotic efflux acrR, marR mutant, evgA, evgS, gadW, ramR
22 Antibiotic efflux pump
pump mutant, mexB, mexF, mexH, mexV, cpxR, sdiA,
smeD, smeE, soxS mutant
MFS antibiotic efflux arlR, arlS, efmA, emrA, emrB, evgA, evgS, lrfA,
13 Antibiotic efflux pump
pump pmrA, qacA, qacB, qepA2, soxS mutant
MATE transporter cdeA, hmrM 2 Antibiotic efflux pump
ABC antibiotic efflux
efrA, efrB, patB, soxS mutant 4 Antibiotic efflux pump
pump
QR genes gyrB, parC and parE conferring FQR 3 Drug targets alteration
Quinolone resistance
QnrS4, QnrS7, QnrVC7 3 Drug target protection
proteins (Qnr)
P. aeruginosa CpxR
marR mutant
ramR mutant
sox S mutant
E. coli acrA
QnrVC7
QepA2
mex H
sme D
hmrM
QnrS2
QnrS4
cme C
cme A
mex V
cme B
mex B
mex F
sme E
gadW
efm A
emrA
pmrA
ade N
emrB
ade L
cde A
qac A
qac B
evg A
pat B
evg S
acrS
sdi A
efrA
arlR
efrB
arlS
CRP
IrfA
CC1802 47 47 72 58 50 48 44 44 43 49 43 50 52 46 58 56 45 50 56 55 49 52 49 46 49 45 42 45 55 56 59 76 49 50 49 45 41 39 49 50 44 51 55
CC1803 47 47 72 58 50 48 44 44 43 49 43 50 52 46 58 56 45 50 56 55 49 52 49 46 49 45 42 45 55 56 59 76 49 50 49 45 41 39 49 50 44 51 55
CC1805 47 47 72 58 50 48 44 44 43 49 43 50 52 46 58 56 45 50 56 55 49 52 49 46 49 45 42 45 55 56 59 76 49 50 49 45 41 39 49 50 44 51 55
CC1808 47 47 72 58 50 48 44 44 43 49 43 50 52 46 58 56 45 50 56 55 49 52 49 46 49 45 42 45 55 56 59 76 49 50 49 45 41 39 49 50 44 51 55
SP1802 49 46 67 54 54 48 68 44 45 48 44 49 56 47 58 58 44 50 55 55 49 71 50 46 51 56 43 45 51 59 59 79 48 50 48 45 37 41 40 53 51 55
SP1805 49 46 67 54 54 48 68 44 45 48 44 49 56 47 58 58 44 50 55 55 49 71 50 46 51 56 43 45 51 59 59 79 48 50 48 45 37 41 40 53 51 55
SP1809 49 46 67 54 54 48 68 44 45 48 44 49 56 47 58 58 44 50 55 55 49 71 50 46 51 56 43 45 51 59 59 79 48 50 48 45 37 41 40 53 51 55
0 50 100
123
Color key
Heat map with similarity percentage of all QR genes
RESULTS & DISCUSSION
Antimicrobial resistance genes
prediction
Quinolone resistance (QR) gens
124
RESULTS & DISCUSSION
Chromosomal mutations
prediction
▪ 13 chromosomal
mutations were
predicted from Resfinder
Resfinder
- 16S_rrsB
- 16S_rrsC
- 16S_rrsH
- 23S
- ampC
- folP
- gyrA
- gyrB
- parC
Mutation identification by - parE
Mega7 software - pmrA
- pmrB
- rpoB
125
RESULTS & DISCUSSION
Quinolone
Quinolone
126
CONCLUSION
127
Output of this study
128
Research team
132